The University of Queensland COVID-19 vaccine with Professors Paul Young and Trent Munro

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/b5/51/e7/b551e72b-bc7a-a10a-b90a-95f919c6b41a/mza_10872013384498953585.jpg/600x600bb.jpg

COVID19 Road to a vaccine

MVEC

18 episodes

8 months ago

The year 2020 has seen the emergence of the SARS-CoV-2 virus (COVID19), a unique and potentially devastating virus, with no known prevention or treatment. This new SARS-CoV-2 virus has shown to not only have significant international health implications, but also immense psychological and economic impacts. Associate Professor Nigel Crawford, a vaccinologist and consultant paediatrician at the Murdoch Children’s Research Institute (MCRI) & Royal Children’s Hospital (RCH), Melbourne, will delve into the global pursuit of a safe and effective vaccine to prevent COVID19. This is all occurring at ‘pandemic speed’ and MVEC’s new podcast will explore this complicated and multi-faceted process through interviews with a variety of national and international vaccine experts.

Medicine

Health & Fitness

RSS

All content for COVID19 Road to a vaccine is the property of MVEC and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/89a7f3d037c7a3c66e8b53401be97e50.jpg

The University of Queensland COVID-19 vaccine with Professors Paul Young and Trent Munro

COVID19 Road to a vaccine

34 minutes

5 years ago

The University of Queensland COVID-19 vaccine with Professors Paul Young and Trent Munro

In episode 10 of our COVID19 Road to a vaccine series, our host, Nigel Crawford, speaks with Professors Paul Young and Trent Munro to discuss the University of Queensland (UQ) COVID-19 vaccine candidate. UQ and CEPI (the Coalition for Epidemic Preparedness and Innovation) have partnered with CSL (Seqirus) to advance their novel molecular clamp technology to develop their vaccine for COVID-19. This vaccine has recently progressed to Phase 1 clinical trials. In this episode they discuss:

•The University of Queensland COVID19 vaccine development process
•The involvement of CEPI in their trial
•The use of a molecular clamp platform in the development of their protein SARS-CoV-2 vaccine
•Results of their preclinical trials
•Their partnership with CSL/Seqirus and the use of the MF59 adjuvant
•The timeline of their clinical trials and the upcoming steps

Links:

CEPI partners with University of Queensland to create rapid response vaccines:
https://cepi.net/news_cepi/cepi-partners-with-university-of-queensland-to-create-rapid-response-vaccines/

Dosing begins in the first human trial of UQ’s COVID-19 vaccine
https://stories.uq.edu.au/news/2020/first-human-trial-of-UQs-COVID-19-vaccine/index.html

The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate:
https://www.csl.com/news/2020/20200605-uq-cepi-and-csl-partner-for-covid-19-vaccine-candidate